Epocrates Inc.

• Battle over "Mobile Healthcare"

  By Mike Thiessen - January 15, 2013 | Tickers: ATHN, EPOC, WBMD

  Electronic health record and practice management provider Athenahealth (NASDAQ: ATHN) recently announced its intention to purchase mobile medical-reference and "point-of-care" provider Epocrates (NASDAQ: EPOC) for about $293 million in cash. Under the terms of the formal offer, San Mateo, California-based Epocrates shareholders would receive cash payouts of $11.75 per share. No options or purchase warrants would be extended or exchanged. Depending upon the speed with which it is approved more »

• Is WebMD a Good Stock to Buy Right Now?

  By Meena Krishnamsetty - April 18, 2012 | Tickers: EPOC, WBMD

  The Healthcare Information Technology (HCIT) sector has traded well into the 30.0x forward multiple range in the past given White House support for a move toward electronic medical records, cost cutting, and initiatives focused on technological advancement. WebMD (NASDAQ: WBMD), which runs WebMD.com and Medscape.com, does not exactly operate in the EMR or cost management space, but it does provide healthcare information. Its websites serve as touchpoints more »

• J.P. Morgan Healthcare Conference Schedule: Day One

  By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

  The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

  I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)